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BOVINE AORTIC ARCH: A MARKER FOR THE DEVELOPMENT AND PROGRESSION
OF THORACIC AORTIC DISEASE. Matthew Hornick, Remo Moomiaie, Hamid Mojibian,
Esther. S. Lee, John A. Rizzo, Maryann Tranquilli, and John A. Elefteriades. Section of Cardiac
Surgery, Department of Surgery, Yale University, School of Medicine, New Haven, CT.
This study investigated the relationship between congenital bovine arch (BA) variant and
thoracic aortic aneurysm (TAA), thoracic aortic expansion rate, bicuspid aortic valve (BAV), and
aortic complications. We hypothesized that BA would be significantly associated with the
presence and progression of thoracic aortic disease.
To determine prevalence of BA, we retrospectively reviewed thoracic CT and/or MRI
scans of 616 patients with thoracic aortic disease and 844 patients without thoracic aortic disease
(all from Yale-New Haven Hospital). In patients with thoracic aortic disease, we assessed
accuracy of official radiology reports in citing BA, and reviewed all available hospital records to
determine disease location, thoracic aortic growth rate, presence of bicuspid aortic valve (BAV),
and prevalence of thoracic aortic dissection and rupture in patients with and without BA.
BA was observed in 26.1% of patients with thoracic aortic disease and 16.4% of patients
without thoracic aortic disease (P<0.001). Radiology reports cited BA in only 16.1% of patients
with aortic disease and concomitant BA. There was no association between BA and location of
aortic disease, prevalence of dissection (P=0.39), or presence of BAV (P=0.68). Rate of aortic
expansion was 0.29 cm/year in the BA group and 0.09 cm/year in the non-BA group (P=0.003).
Mean age at initial aortic repair was 56.2 years in BA patients and 61.4 years in non-BA patients
(P=0.0004).
Our findings suggest that BA is indeed associated with both the development and
progression of thoracic aortic disease, and support the following conclusions: 1) BA is
significantly more common in patients with thoracic aortic disease than in the general population.
2) Radiologists often overlook BA. 3) BA is not significantly associated with BAV, aortic
dissection, or disease at any particular location within the thoracic aorta. 4) BA is associated with
elevated TAA growth rate and earlier repair.
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INTRODUCTION

Bovine Aortic Arch
―Bovine arch‖ (BA) refers to a group of congenital variants of the great vessels of the
aorta in which there is aberrant origin of the left common carotid artery. In the most frequently
observed bovine arch variant in humans, there is a common origin of the left common carotid and
innominate arteries, such that the left common carotid and innominate branches arise from the
same trunk (Fig. 1). In a less frequent variant, the left common carotid artery originates from the
innominate artery proper, such that there is distance along the innominate artery between the
aorta and the origin of the left common carotid (Fig. 1) [1,2]. For purposes of this study, we will
refer to the former configuration as type 1 BA, and the latter configuration as type 2 BA. Both
configurations are typically classified under the general heading ―bovine arch‖ [1].

Figure 1. Anatomic configurations of ―bovine arch‖ in humans (type 1 BA on L, type 2 BA on R)
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Nomenclature
There is much speculation as to the origin of the ―bovine‖ designation, since it is, in fact,
a misnomer – a true BA, that is, what is observed in bovine species, consists of a single root
branching from the aortic arch from which all four great vessels (right subclavian, right common
carotid, left common carotid, left subclavian) originate [1]. Some have postulated that this
anatomically incorrect designation stems from the resemblance of the human variant branching
pattern to the appearance of cattle horns [3]. Others have proposed re-naming the variant
altogether – Elster suggests ―canine, feline, or lapine arch‖ in light of the similarity of the human
branching pattern to the aortic arch of dog, cat, and rabbit species [4]. Berko proposes ―simian
arch‖ due to the biologic similarities between humans and monkeys, and the frequent use of
simian models when studying human physiology [5,6]. Despite considerable controversy, the
misnomer ―bovine arch‖ has endured to this point.

BA Prevalence in the General Population
Dating back to the mid-1800s, several autopsy studies and thoracic imaging reviews have
sought to determine the prevalence of BA (and other variant branching patterns) in the general
population, with great variability in sample size and results. Estimates of BA prevalence have
ranged from 1% to 27.4% over the last century [7-20], and from 8.7% to 27.4% in two large
computed tomographic angiography (CTA) series published during the last two years alone
[17,20]. Type 1 BA is generally regarded as the more common anatomic sub-variant, with
reported prevalence typically about twice as high as type 2 BA (average estimates hover around
10% and 5%, respectively, in the general population) [2]. As mentioned, however, extremely
disparate findings have been published in studies of different types and sizes.
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Clinical Significance of BA
While the true prevalence of BA in humans has been a topic of interest and speculation,
to date there is a paucity of literature specifically addressing clinical implications of the presence
of BA in patients. Historically, BA has been regarded as a ―normal,‖ clinically insignificant
anatomic variant, often incidentally discovered on thoracic imaging studies or during thoracic
surgery. BA has been a particularly frequent finding in patients undergoing aortic and aortic arch
vessel interventions, but few authors have gone so far as to suggest an association between BA
and thoracic aortic disease [21-32].

BA and Aortic Catheterization
BA seems to be associated with technical failure and neurological complications in
carotid stenting procedures, but this reflects the challenge of traversing variant anatomy with a
catheter rather than the natural history of the BA aorta itself [21-24]. Although percutaneous
carotid revascularization is typically performed via the femoral approach, the presence of BA
increases the technical complexity of this technique. Accessing the left common carotid from the
femoral vessels in the context of BA requires increased catheter flexibility, and risks perforating
the common trunk [21,22]. Several reports recommend an alternative approach, either via the
right radial or brachial artery, to safely stent the left common carotid in patients with BA anatomy
[21-24].

BA in Blunt Chest Trauma
Multiple case reports highlight a potential association between BA and traumatic vascular
injury [25-30]. Innominate artery rupture (at its takeoff from the aortic arch) is the most common
traumatic injury involving the aorta and great vessels, and BA seems to be associated with an
increased likelihood of innominate transection [25]. One retrospective study of patients who
experienced blunt chest trauma found that 29% of patients with bovine arch sustained injury to
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the common trunk, compared to 11% of patients without bovine arch [25]. In the context of chest
trauma, BA – with two great vessels stabilizing the aorta instead of three – may predispose to
increased motion of the aortic arch at the time of sudden deceleration, with consequent sternal
compression of arch vessels contributing to ―traumatic avulsion‖ [25]. Others have noted how
physical principles of arch anatomy dovetail these clinical findings. Specifically, the common
trunk is essentially a fixation point that is nearly perpendicular to the aortic arch, origin of left
common carotid, and left subclavian artery. This orientation of attachments maximizes tension at
the common trunk, thereby predisposing to injury at this site when these attachments are in
motion (as in acute deceleration) [26]. The observed association between BA and traumatic injury
of the aorta and great vessels is thought to be purely mechanical in nature, and specific to the
setting of trauma, rather than a reflection of the natural history of these vessels in the presence of
the variant.

BA in Aortic Arch Procedures
BA has also been reported as an incidental finding in patients with atraumatic aortic
disease. Type 2 BA variant appears to facilitate bilateral selective antegrade cerebral perfusion, a
technique employed in aortic arch operations requiring deep hypothermic circulatory arrest
[31,32]. Typically this mode of cerebral perfusion involves right axillary artery cannulation to
perfuse the right common carotid artery (with proximal clamping of the innominate) and direct
cannulation of the left common carotid to ensure bilateral cerebral blood supply. Several reports
suggest the relative ease of bilateral cerebral perfusion when the left common carotid artery arises
directly from the innominate artery (type 2 BA). Provided that there is adequate distance along
the common trunk between the aorta and the takeoff of the left common carotid to clamp
proximally on the common trunk, perfusion through a right axillary cannula then perfuses both
common carotid arteries without the need for left carotid cannulation (which is a risk factor for
dissection and rupture) [31,32]. All such reports attesting to the utility of BA in aortic arch
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procedures imply an association between BA and aortic disease, but this possibility has yet to be
explored in depth.
BA Prevalence in Turner’s Syndrome
BA has been reported with increased frequency in studies investigating anatomic
correlates of Turner’s syndrome, an inherited condition resulting from X monosomy or XX
mosaicism (45,X or 45,X/46,XX, respectively) that predisposes to aortopathy. Abnormalities of
the heart and great vessels are detected in nearly 50% of all women with Turner’s, with BAV,
aortic coarctation, and elongated transverse arch particularly common in this population [33]. A
prospective MRI study comparing prevalence of arterial anomalies in women with and without
Turner’s syndrome found a 28.6% BA prevalence in the Turner’s group (98 patients) compared to
a 12.1% BA prevalence in the control group (33 patients). Although BA was not significantly
associated with ascending aortic aneurysm, the study did not account for longitudinal aortic
growth, and the control group was far too young to accurately represent prevalence of aortic
disease (mean age 37) [34]. Nonetheless, BA certainly seems to be associated with Turner
syndrome, and coexists with BAV and ascending aortic disease in many of these patients.

BA, Valvular Pathology, and Aortic Disease
A small number of reports have hinted at a possible association between BA, bicuspid
aortic valve (BAV), and ascending aortic disease in non-Turner’s patients, but the literature to
support this claim is scant at best. In one of the aforementioned case reports discussing bilateral
selective cerebral antegrade perfusion, the authors present a series of three consecutive patients
undergoing repair for bicuspid valve and ascending aortic aneurysm who were found to have
concomitant BA. They briefly touch upon two possible explanations for this observed overlap
between BAV and BA: (1) an ―incidental correlation‖ between bovine arch, bicuspid valve, and
ascending aortopathy, or (2) an ―anatomic predisposition to a syndrome involving the left
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ventricular outflow tract‖ [31]. While the link between BAV and ascending aortic disease is wellestablished, the proposed connection between BA and either BAV or ascending disease has yet to
be investigated.

Embryology of BA
The precise embryologic events underlying the development of common origin of the
innominate and left common carotid arteries remain incompletely understood. However, several
studies suggest that the aortic cusps, left ventricular outflow tract, and the arterial media of
ascending aorta, aortic arch, and arch vessels (including the innominate and left common carotid)
originate from the neural crest, and are thus embryologically linked [35-37]. Given this potential
association, it seems entirely plausible that BA (a variant of great vessel morphology) might be
associated with both BAV (a disorder of the aortic cusps) and ascending aortopathy (a disorder of
the aortic media).

In summary, a small number of case reports and a few studies of aortic anatomy in
patients with Turner’s syndrome hint at a possible link between congenital BA variant and later
development of aortopathy. Clinicians within our own group have noted in general terms that BA
is relatively common in patients with thoracic aortic aneurysm (TAA)—BA is frequently
observed intraoperatively in patients undergoing TAA repair or replacement. To date, however,
no large study has thoroughly investigated the potential association between BA and thoracic
aortic disease.

Clinical Aspects of Thoracic Aortic Disease

Aortic Anatomy
The human aorta consists of three layers: intima on the luminal aspect, media internally,
and adventitia externally. The media consists of elastin and collagen fibers, smooth muscle cells,
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and an amorphous ground substance rich in polysaccharides, and is particularly relevant to aortic
disease since it confers elasticity and hence resistance to dilatation [38]. Medial components are
organized in discrete units called lamellae, with a relatively fixed distribution of lamellae in
particular portions of the aorta. Specifically, the ascending aorta (35-46 lamellae) contains a
higher number and a higher density of lamellae than the descending aorta (25-28 lamellae) [39].

Physics of the Aorta
From a mechanical perspective, the aorta is a tubular vessel through which pressurized
pulsatile blood flows, and hence is subject to basic physical principles. Laplace’s law states that
wall tension within such a vessel is directly proportional to both the pressure of fluid within the
vessel and the diameter of the vessel, while wall thickness and elasticity absorb radial force and
effectively temper wall tension [40]. To validate the clinical relevance of Laplace’s law, Okamoto
et al. used aortic tissue models to demonstrate that aortic wall stress increases linearly with
diameter and systolic blood pressure [41].

Definition, Classification, and Demographics of TAA
While the precise size criterion for defining aortic aneurysm remains a topic of debate, a
thoracic aorta with a diameter greater than 4.0 cm is typically recognized as abnormal.
Aneurysms come in two distinct morphologic varieties – fusiform, which is a dilatation of the
entire circumference of the aorta, and saccular, which is an abnormal outpouching of only a
portion of the vessel’s circumference. Aneurysms occur in all regions of the thoracic aorta, and
may be classified on this basis as well – aneurysms of the descending thoracic and
thoracoabdominal aorta, for example, are more prevalent than aneurysms of the ascending aorta
and aortic arch [39]. The incidence of thoracic aortic aneurysm is thought to be 6 per 100,000
people per year [42], affecting men and women roughly equally but presenting earlier in men (on
average, men present in their early 60s, while women present in their mid- to late-70s) [43]. Most
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TAAs are asymptomatic, and are discovered incidentally on thoracic imaging obtained for other
reasons.
Because many diseased aortas escape detection until after catastrophic complications take
place, thoracic aortic disease is frequently lethal. A recent CDC estimate cites aortic disease as
the 17th most common cause of death in all individuals and the 15th most common cause of death
in individuals over age 65 [44], despite improved methods of detection and treatment. Deaths
most often occur secondary to aortic dissection or rupture, acute events that typically arise in the
setting of progressive aortic dilatation. Patients with untreated TAAs demonstrate an extremely
high risk of eventual complication, with aortic rupture causing death approximately 50% of the
time [45].

Aortic Dissection: Definition
In ―classic‖ aortic dissection, an intimal tear allows pressurized blood to enter the aortic
wall, which then propagates through a split, or ―dissected,‖ medial layer. This splitting of layers
establishes two distinct lumens for blood flow, denoted true (referring to the vessel’s original
lumen) and false (referring to the lumen created by the intimal tear). The Stanford system
classifies thoracic aortic dissection according to the location of intimal disruption: type A
dissection originates in the ascending aorta or arch, and type B dissection originates in the
descending aorta. Type A frequently arises just distal to the sinotubular junction, whereas type B
classically originates just distal to the takeoff of the L subclavian artery. Both type A and type B
dissections very frequently propagate through the full extent of the thoracic (and abdominal) aorta
distal to their point of origin [39].
Acute Dissection: Indications for Emergent Repair
Aortic dissection is potentially life-threatening. Splitting renders the aortic wall
inherently weaker, since the outer medial and adventitial layers of the dissected aorta, normally
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shielded by the full thickness media, are exposed to luminal pressures. In an early natural history
study, 77% of patients with untreated dissection ultimately ruptured, presumably owing to
compromised aortic wall integrity [45]. Moreover, blood flow may be impaired through one or
both lumens in a dissected vessel, which can disrupt perfusion to any of the numerous critical
branches originating from the aorta. Dissection may ultimately cause death via four distinct
mechanisms: (1) intrapericardial rupture leading to cardiac tamponade; (2) free rupture of
descending dissection leading to pleural hemorrhage; (3) acute aortic insufficiency (secondary to
dissection through the aortic valve orifice); (4) occlusion of any branch of the aorta, from the
coronary arteries to the iliac bifurcation, with distal end-organ malperfusion [39]. It is now
common practice to urgently repair all acute type A dissections to prevent devastating valvular
complications and/or cardiac tamponade. Operation typically involves completely replacing the
intimal flap and dissected ascending aorta with a Dacron graft. Conversely, most uncomplicated
type B dissections are managed medically (with anti-hypertensive medications), given the high
risk of spinal cord injury and paraplegia in descending aortic operations. Urgent intervention
remains warranted if type B dissection leads to acute rupture or branch occlusion with end-organ
damage. Patients with type A dissections that extend through the arch and descending aorta
typically undergo initial repair or replacement of the ascending segment, with subsequent
monitoring of the dissected descending segment [39].

Chronic Dissection and Variants
Not all dissections are lethal, and many patients with subacute type A dissections and
uncomplicated type B dissections are managed with anti-hypertensive medications in lieu of
immediate surgical repair. Patients who survive acute events develop chronic dissections, in
which flow may either persist through both the true and false lumens, or the false lumen may
partially or completely thrombose [46]. Variant presentations of dissection include intramural
hematoma and penetrating aortic ulcer, both of which tend to be chronic in nature. Intramural
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hematoma refers to a circumferential medial hematoma in absence of a detectable intimal flap; its
origin is controversial, and may result from classic dissection or from rupture of the vasa vasorum
supplying the aortic wall. Penetrating aortic ulcers, which are typically encountered in the setting
of severe aortic atherosclerosis, result from erosions into atherosclerotic plaque that ultimately
perforate the aortic intima and allow blood to enter the media. Like acute dissection, all variants
of chronic dissection weaken the aortic wall, predisposing to accelerated aortic dilatation and
ultimately rupture, and thereby require regular imaging follow-up [39].

Indications for TAA Repair
Although acute events do occasionally occur in smaller aortas, the risks of dissection
and/or rupture generally rise with increasing aortic diameter. Several database studies by the Yale
group and others have delineated the median size at which aneurysmal thoracic aortas dissect or
rupture in order to empirically establish criteria for surgical intervention [48-51]. Coady et al.
found that dissection and/or rupture strikes at a median diameter of 6.0 cm in ascending aortas
and 7.2 cm in descending aortas, and identified these dimensions as specific anatomic ―hinge
points‖ beyond which the risk of complication increased sharply – in the ascending aorta, the
prevalence of dissection rose by 32.1% at 6.0 cm, and in the descending aorta, the prevalence of
dissection rose by 43.0% at 7.0 cm. In order for operation to preempt the vast majority of these
complications, the authors recommended a 5.5 cm threshold for repairing ascending aneurysms,
and a 6.5 cm threshold for repairing descending aneurysms [48]. To further illustrate this ―hinge,‖
a more recent study by the Yale group reported annual risk of dissection or rupture as a function
of ascending aortic diameter: 2% per year risk for TAAs < 5.0 cm, 3% per year risk for
aneurysms 5.0-5.9 cm, and 7% per year risk for aneurysms ≥ 6.0 cm [51]. The specific size
criteria outlined here remain the current standard for operative repair in the majority of patients
with thoracic aortic disease. Exceptions do exist – for patients with a concomitant connective
tissue disorder (such as Marfan’s or Ehlers-Danlos, both of which affect extracellular matrix
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proteins in the aortic wall), congenital BAV, or family history of aortic disease, ascending aortic
operation is indicated at diameter ≥ 5.0 cm. Other risk factors that may prompt semi-urgent
intervention at even smaller diameters include the presence of otherwise unexplained symptoms
and/or rapid aneurysm expansion [52,53]. Chronic dissection typically does not influence size
criteria for operative repair, although one study found that descending aortic rupture occurred at
smaller diameters in patients with chronic type B dissection [54].

Growth Rate in Thoracic Aortic Disease
Previous studies by the Yale group and others have sought to better define the natural
history of the pathologic aorta, particularly with respect to rate of diametric growth. Despite
significant variation between individual aortas [50], aortic disease is now widely recognized as an
indolent process, with aneurysmal aortas growing 0.1 cm/year on average. Several factors have
been shown to influence rate of diametric expansion. Location of aneurysm is a particularly
important determinant of mean growth rate, with aneurysmal descending thoracic segments
expanding 0.1 - 0.2 cm/year more rapidly than ascending segments in most studies [48-51].
Although the precise explanation for this discrepancy is unclear, Elefteriades has postulated that
perhaps the higher growth rate reported in descending thoracic aneurysms is attributable to the
comparatively lower density of elastic lamellae in this segment of the aorta [48]. The presence of
chronic dissection is also associated with increased aortic growth rate, expanding approximately
0.2 cm/year faster than non-dissected segments, and presumably for similar reasons – the
adventitial layer contains far fewer elastic lamellae than the medial layer, and in absence of a full
thickness media, the aorta tends to dilate rather than recoil [48-51]. Recent studies have illustrated
a significant association between growth rate and false lumen patency in the context of chronic
dissection, with accelerated aortic expansion observed in descending aortas with patent false
lumens [46,47,55]. Diameter of the aorta at any given point in time is another influential variable,
since, in accordance with Laplace’s law, circumferential wall tension is directly proportional to
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the diameter of the vessel [48,50]. Coady et al. found that average annual growth rate varied from
0.10 cm/year in 4.0 cm ascending aneurysms to 0.19 cm/year in 8.0 cm ascending aneurysms, and
from 0.28 cm/year in 4.0 cm descending aneurysms to 0.56 cm/year in 8.0 cm descending
aneurysms [48]. Bicuspid valve is also known to affect growth rate, as will be discussed.

Growth Rate Measurement
Calculating aortic growth rate presents several technical challenges. Serial aortic imaging
is fraught with inconsistencies, owing to the complex shape of the vessel itself, the multitude of
imaging modalities used to visualize the aorta, and the inevitable variance between different
institutions and different interpreting radiologists. While axial CT and MRI imaging is often used
to size the aorta, the image seen in the axial plane is not necessarily perpendicular to the plane of
the vessel, and thus does not necessarily represent its true diameter. Given the typical curvature of
the ascending aorta, the vast majority of axial slices depict an orthogonal view of much of the
ascending segment. Moreover, different scans may portray the same segment from somewhat
different perspectives, thereby falsely representing changes in the size of the vessel. Growth rate
calculations also assume that interpreting radiologists measure the aorta at exactly the same
location over time, which is extremely unlikely in practice. This inter-observer measurement
variability only compounds the technical challenges inherent to growth rate calculations [56].
Not surprisingly, estimates of aortic growth rate have varied considerably between
studies. Hirose et al. initially utilized an arithmetic calculation – final aortic diameter minus initial
diameter, divided by duration between measurements – to determine growth rate of thoracic
aortic aneurysms [57]. Their first estimate was relatively high (0.42 cm/year), owing at least in
part to their truncation of negative growth rates. Inclusion of negative values is crucial in any
aortic growth rate estimation because these serial measurements accurately reflect inter-scan and
inter-observer variability. Masuda et al., who found a mean annual growth rate of 0.13 cm/yr,
showed that inclusion of negative growth rate values eliminates much of the error associated with
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the arithmetic method [58]. Rizzo developed a novel method for calculating growth rate via
multivariate regression analysis, based on the premise that aortic growth follows an exponential
distribution as a function of aortic size at any particular instant (consistent with Laplace’s law and
clinical data previously discussed) [59,60]. This approach has generated growth rate estimates
that remain widely accepted today—approximately 0.10 cm/year in ascending aneurysms and
0.30 cm/year in descending aneurysms [48].

Mechanisms of Thoracic Aortic Disease

Precise causes of aortic disease are multifold and not yet fully elucidated. The natural
history of the aorta is subject to several variables, including gross anatomic structure, progressive
tissue remodeling and related congenital predispositions, and mechanical influences affecting
circumferential wall stress. Aortic disease reflects a complex interaction of these various
contributing factors.

Mechanical Influences
Laplace’s law explains several basic principles of aortic expansion. First, hypertension
predisposes to aortic dilatation. This has been borne out in the literature, as 60-70% of patients
with aneurysm are hypertensive; moreover, studies investigating the precise timing of thoracic
aortic dissection identify hypertension in times of physical or emotional stress as an important
inciting factor [61-63]. Laplace’s law also predicts that aneurysmal disease begets aneurysmal
disease, since a larger aorta will be subject to greater wall tension, which will, in turn, predispose
to further dilatation (and ultimately dissection or rupture). Several studies have confirmed that
aortic expansion follows an exponential distribution [50,51], and this principle now forms the
basis of regression analyses used to calculate aortic growth rate [60]. In vivo calculations of
ascending aortic wall stress demonstrate how the variables in Laplace’s law, namely aortic
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diameter and blood pressure, contribute concomitantly to the etiology of aortic complications.
Specifically, Koullias et al. showed that when systolic pressure within a 6.0 cm aorta nears 200
mm Hg, aortic wall stress approaches 860 kPa, which exceeds the maximal tensile strength of the
vessel and thereby predisposes to dissection or rupture [64]. Hypertension within a ―hinge point‖sized aorta is thus potentially catastrophic.
Changes in the constitution of the aortic wall itself render the pathologic aorta all the
more vulnerable to mechanical influences. These constitutional changes will be considered at
length in the proceeding sections.

Effects of Aging
Aging inevitably results in some degree of aortic dilatation. With chronic exposure to
high-pressure luminal blood flow, the constitution of the aortic wall evolves over the lifetime, and
progressive remodeling reduces the vessel’s inherent distensibility. Several histologic changes
are observed in the media of the ―normal‖ aging aorta, including: (1) cystic medial necrosis,
characterized by the degradation of elastin and collagen with subsequent pooling of mucoid
material; (2) elastin fragmentation, referring to disruption of lamellar units; and (3) fibrosis,
which is an increase in collagen at the expense of smooth muscle cells [65,66]. As elastin in the
media is degraded and disorganized, the relatively collagenous aorta becomes prone to dilatation
with repeat exposure to luminal blood. Age-related structural changes alone, however, cannot
ultimately account for the full spectrum of aortic disease, since many individuals never develop
clinically significant dilatation or worrisome aneurysms [66].

Ascending Aortopathy
As is the case in aging aortas, tissue specimens from diseased ascending aortas typically
exhibit some form of medial degeneration. In pathologic aortas, however, these degenerative
medial changes occur earlier and to a greater extent than in normal aging, predisposing to more
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radical dilatation (that often presents in younger age groups). Much of our understanding of the
pathophysiology of aortic wall degeneration stems from studies of Marfan’s syndrome and
bicuspid aortic valve (BAV), two conditions that predispose to premature ascending aortic
disease [67].
Marfan’s-associated ascending aneurysms are related to a congenital deficiency in
fibrillin-1, a component of the aortic media that contributes to tissue elasticity by linking vascular
smooth muscle cells to adjacent elastin fibrils. In addition, matrix metalloproteinases, which
function primarily in the degradation of extracellular matrix, are upregulated in ascending aortas
of Marfan’s patients (relative to healthy controls), and have subsequently been implicated in the
etiology of ascending aortic dilation in non-syndromic patients as well [67-69].
Bicuspid aortic valve (BAV) will be considered in greater detail in this study because of
its extremely high prevalence in ascending aortic disease and its potential association with BA (as
discussed previously). BAV is a congenital anomaly present in 1-2% of the general population
that is frequently associated with early aortic stenosis and ascending aortopathy; prevalence of
ascending aortic dilatation in BAV patients has ranged from 40-70% in several natural history
studies [70-73]. This association between BAV and ascending aneurysm is well-established, but
the underlying mechanism has been a point of controversy. Ascending disease in the setting of
BAV was initially thought to be hemodynamic in nature, with post-stenotic dilatation presumably
resulting from turbulent flow through the deformed valve [35,74]. A significant body of evidence,
however, suggests that ascending aortopathy in BAV disease is a consequence of progressive
tissue abnormalities rather than post-stenotic hemodynamic effects. Several studies have shown
that proximal aortic enlargement in BAV patients occurs irrespective of the type or degree of
valvular dysfunction [71,73,75,76], and one group demonstrated that valve replacement in BAV
patients does not affect subsequent progression of aortic dilatation [77]. Tissue analyses have
further substantiated the notion of intrinsic aortic wall abnormalities associated with BAV. In
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aortic specimens from patients who underwent ascending aortic replacement, several pathologic
findings were more pronounced in patients with BAV than in patients with tricuspid aortic valve
(TAV), including cystic medial necrosis, elastin fragmentation, and changes in smooth muscle
orientation [78]. Moreover, patients with BAV appear to have thinner and more sparsely
distributed elastic lamellae in their ascending aortic media [79].
Many of the tissue abnormalities seen in aortas of Marfan’s patients, such as fibrillin-1
deficiency and MMP overexpression, have been encountered in BAV patients as well. Fedak et
al. suggested that deficient fibrillin-1 in BAV ascending aortas might prompt MMP-mediated
matrix remodeling and ultimately aortic dilatation, and went on to postulate that congenital BAV
results from inherited defects in genes regulating fibrillin-1 integration into ECM (there is no
evidence yet to support this particular claim) [80]. Recent molecular analyses of aortic tissue in
BAV patients have indicated that imbalanced expression of MMPs and their endogenous
inhibitors (TIMPs) might underlie ascending aortic disease in this group. Koullias et al. found that
MMP-2 and MMP-9 levels were elevated in BAV relative to TAV aortas, whereas TIMP-1 was
lower in BAV tissue [81]. Several studies affirm the primary role of MMP-2 and MMP-9 in the
etiology of ascending disease [80,82], while others suggest that TIMP downregulation is the
primary intrinsic wall abnormality underlying ascending dilatation [83]. Moreover, not only do
expression profiles of MMPs and TIMPs differ in BAV and TAV patients, but MMP expression
appears to depend in part on TAA size, perhaps suggesting that MMP and TIMP levels fluctuate
throughout the natural history of each individual aorta [84,85]. Further investigation is necessary
to determine if MMP is inherently overexpressed in diseased aortas, or if underlying mechanical
triggers ultimately promote MMP upregulation [86].
Natural history studies suggest that BAV is associated with both the presence and
expansion of ascending aortic aneurysms. As mentioned, approximately 50% of BAV patients
ultimately develop clinically significant ascending aortic dilatation [73]. Davies et al. reported in
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a Yale database review that BAV patients presented with ascending aneurysm far earlier than
patients in the TAV group (49.0 years versus 64.2 years), and also exhibited significantly higher
ascending aortic growth rates (0.19 cm/year, versus 0.13 cm/year in TAV patients) [87]. Ferencik
reported slightly lower aortic growth rates in the setting of BAV, with highest mean expansion
rate 0.09 cm/year in the proximal ascending aorta [75].
Recently, several genetic mutations have been implicated in the pathogenesis of BAV
and concomitant ascending aortopathy, but most remain speculative. There is at the very least
strong evidence that the association between BAV and ascending aortic disease is largely a
consequence of progressive congenital tissue abnormalities in the aortic wall.

Descending Aortopathy
Ascending and descending aortic disease exhibit markedly different characteristics, and
in fact appear to be distinctly different pathologic processes. While ascending disease is typically
associated with medial degeneration, descending disease is most frequently characterized by
aortic arteriosclerosis [39]. One thought is that intimal plaque deposition triggers inflammatory
changes that increase proteinase activity in the media, ultimately weakening the descending aortic
wall [88]. This theory, however, fails to account for the large percentage of patients with aortic
atherosclerosis who never develop aneurysmal disease [89]. Agmon et al. suggest that
atherosclerosis has a limited role in aneurysm formation, citing a weak relationship between
atherosclerosis and distal thoracic aortic diameter [90]. Scherer hypothesized that descending
aortic dilatation may actually predispose to atherosclerosis, suggesting that as the aorta dilates,
hemodynamic forces cause subintimal proliferative changes resulting in plaque formation [91].
All such theories are controversial, and many have postulated that the link between
atherosclerosis and descending aortic disease is associative rather than causative. Molecular
analyses of pathologic descending aortic tissue have demonstrated the importance of MMPs in
the etiology of dilatation, as has been observed in ascending aortic disease. Specifically, MMP-9
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expression predominates in the anterior wall of descending aortic aneurysms, where diameter is
most volatile [86]. Ascending TAAs and infrarenal abdominal aortic aneurysms (AAAs) are
characterized by distinct gene expression patterns, and it seems likely that descending TAAs
exhibit a distinct molecular profile as well [92].
Natural history studies indicate that acute aortic complications are a significant risk in
descending TAAs, with descending rupture occurring in approximately 20% of untreated patients.
Risk factors for descending aortic rupture and/or dissection parallel what has been observed in
ascending aortopathy—while size appears to be the most important single criterion for operative
intervention, growth rate and symptoms are also significant indications [93]. Descending and
thoracoabdominal aneurysms tend to grow more rapidly than ascending aneurysms, likely due to
regional differences in elastin content of the aortic wall (as already discussed). That being said,
dissection and rupture in descending disease generally occurs at larger aortic diameters [48,54].

Heritability of Thoracic Aortic Disease
Ascending aortopathy is frequently encountered in association with specific genetic
syndromes affecting connective tissues, including Marfan’s syndrome, Ehlers-Danlos syndrome,
and Turner’s syndrome, among others [67]. Non-syndromic ascending aortic disease appears to
be heritable as well, with several studies demonstrating a significant predisposition to thoracic
aortic disease in first-degree relatives of thoracic aortic disease patients [94,95]. Albornoz et al.
found that 21% of non-syndromic thoracic aortic disease patients have first-degree relatives also
affected by the disease, with the majority of these patients exhibiting an autosomal dominant
inheritance pattern. Moreover, ―familial‖ TAAs presented earlier (58.2 years) and expanded more
rapidly (0.21 cm/year) than ―sporadic‖ TAAs (65.7 years and 0.16 cm/year, respectively), leading
the authors to postulate that familial aortic disease constitutes a more aggressive clinical entity
[96]. Multiple gene loci predisposing to non-syndromic ascending aortopathy have now been
identified, suggesting that ascending disease in families is subject to significant genetic
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heterogeneity [97-100]. Descending aortic disease also appears to harbor a genetic component,
with a possible association between descending TAAs and AAAs in first-degree relatives [96].

Study Rationale and Aims

The BA literature, as well as our own clinical experience, point toward a potential
association between BA and thoracic aortic disease. Like bicuspid aortic valve (BAV), BA is a
congenital abnormality that may predispose to progressive tissue abnormalities in the aortic wall.
Moreover, given the variant’s deviance from standard arch anatomy, its potential to alter flow
mechanics through the aorta must not be overlooked.
TAA is a lethal condition that is nearly always asymptomatic until rupture or dissection;
thus, it is critical to identify markers associated with the development of aortic disease. Moreover,
since diseased aortas demonstrate a highly variable natural history, it is important to define
markers for disease progression in patients with known aortopathy. BA is a congenital variant,
and so is present throughout life, both before aortic disease develops and during the course of the
disease itself.
This retrospective study aims to better define the association between BA and the
prevalence and progression of thoracic aortic disease. We intend to explore potential relationships
between BA and TAA, BAV, aortic growth rate, dissection, and rupture. If a true association
exists between BA and thoracic aortic disease, it is our hope that the presence of BA on thoracic
scan may be used as a marker for increased risk of TAA development, progression and
complications.
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METHODS

Patient Population, Definitions, and Demographics
The present study is part of a broad, on-going investigation of TAA approved by the Yale
Human Investigation Committee. We retrospectively recruited patients for this study from a
population of 947 consecutive patients seen at the Yale Center for Thoracic Aortic Disease
between June 2003 and June 2010.
For purposes of this study, ―thoracic aortic disease‖ was defined as any one of the
following: (a) TAA (thoracic aortic diameter ≥ 4.0 cm per at least one imaging report), (b)
thoracic aortic dissection (intramural hematoma and/or classic dissection with a visible intimal
flap) or thoracic aortic rupture, or (c) history of thoracic aortic surgical repair for symptomatic
dilatation. Only patients with thoracic aortic disease (by these criteria) and at least one thoracic
computed tomography (CT) scan or magnetic resonance imaging (MRI) scan on record at YaleNew Haven Hospital (with adequate visualization of the aortic arch vessels) were included. Of
the 947 eligible patients, 26 were excluded because they did not meet criteria for thoracic aortic
disease, 301 were excluded because they had no thoracic images available for review at YaleNew Haven Hospital, and 4 were excluded due to inadequate visualization of arch vessels on
thoracic scan. The remaining 616 patients (416 male, 200 female) comprised our study
population. Of these 616 patients, 450 had TAA and no thoracic aortic dissection, 149 had
thoracic aortic dissection (76 type A, 73 type B), 16 had thoracic aortic rupture, and 1 patient
underwent operative repair for symptomatic dilatation at aortic diameter < 4.0 cm.
Control Group
A control group of 844 patients (396 male, 448 female) without thoracic aortic disease
was randomly selected from Yale-New Haven Hospital imaging records. A random number
generator was used to designate specific dates between May 2006 and May 2008, and then used

21

again to randomly select 25% of the patients who underwent thoracic CT scans at Yale-New
Haven Hospital on each of those specific dates. Patients made eligible in this fashion were
included in the control group only if (a) they were at least 18 years old at the time of the scan, (b)
the scan clearly demonstrated aortic arch anatomy, and (c) there was no evidence of thoracic
aortic disease by the aforementioned criteria on the scan of interest or on subsequent scans, which
were also reviewed for each eligible patient. Mean age at time of thoracic CT scan was 55.7
years.
Prevalence of BA Variant
To determine the presence or absence of BA variant in the 616 patients with thoracic
aortic disease and the 859 patients without thoracic aortic disease, their thoracic CT and/or MRI
scans were retrospectively reviewed by our team and then confirmed by a cardiac imaging
specialist in the Department of Radiology. All scans were reviewed in all available planes,
including axial, coronal, and sagittal images, as well as multi-planar reconstructions. Patients
were deemed BA+ if the point of separation of the innominate and left common carotid arteries
was visualized cephalad to the plane of greater curvature of the arch in all available views.
BA Type (see Fig. 1)
BA+ patients were classified as ―type 1‖ if the innominate artery and left common carotid
artery shared a common trunk – that is, if the left common carotid artery originated partially from
the aorta rather than entirely from the innominate artery. BA+ patients were classified as ―type 2‖
if the left common carotid artery branched directly and exclusively from the innominate artery
proper, such that there was distance (along the innominate artery) between the origin of the left
common carotid artery and the aorta itself.

22

Citation of BA Variant
For patients with thoracic aortic disease, all imaging reports accompanying CT or MRI
scans were screened for radiologists’ citation of the presence of BA variant. Imaging reports were
compared with our own findings to assess the accuracy and completeness of standard radiology
reports in documenting arch anatomy.
Demographics
Information regarding gender, presence or absence of hypertension, family history of
aortic disease (defined as any relative with thoracic aortic disease and/or AAA), age at
presentation (age at which TAA, dissection, or rupture was initially discovered), and dates of
operative repair was obtained from scans, imaging reports, and Yale Center for Thoracic Aortic
Disease chart records.
Location of Thoracic Aortic Disease
For each of the 616 patients with thoracic aortic disease, location of disease was defined
as (a) ascending (including aortic root), (b) aortic arch, or (c) descending (including
thoracoabdominal). Patients with a history of TAA were classified according to aortic region with
greatest absolute diameter prior to operation. In patients with a history of operative aortic repair
and no record of aortic diameter prior to operation, the region initially repaired was considered
the affected location, regardless of subsequent dilatation or repair in other regions. Patients with
thoracic aortic dissection who did not meet criteria for TAA (diameter < 4.0 cm) and did not
undergo operative aortic repair were classified according to region of initial intimal disruption.
We calculated the proportion of patients in the BA and non-BA groups with disease at each
location.
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Prevalence of Dissection and Rupture
Information regarding presence of dissection and/or rupture was obtained from thoracic
scans, imaging reports, and Yale Center for Thoracic Aortic Disease chart records. Dissection
was classified as type A or type B, according to the Stanford classification system. We calculated
prevalence of overall dissection, type A and type B dissection, and aortic rupture in all BA and
non-BA patients with thoracic aortic disease. We also compared prevalence of dissection and
rupture in BA and non-BA patients with concomitant BAV, and in patients with type 1 and type 2
BA.
Aortic Growth Rate
For all patients with thoracic aortic disease, serial measurements of aortic diameter were
obtained from imaging reports associated with thoracic CT and MRI scans from Yale-New Haven
Hospital, as well as records of imaging reports from CT and MRI scans performed at outside
hospitals. Echocardiographic findings were not included. For patients whose measurements prior
to initial surgical repair could not be obtained, but who later developed TAAs in other locations,
these post-repair measurements were used to determine growth rate. Serial aortic measurements
were available for 217 patients. Patients with serial follow-up were excluded from the growth rate
calculation if duration of radiographic follow-up did not exceed three months. 8 patients in the
BA group and 10 patients in the non-BA group were excluded by these criteria. For patients in
whom acute dissection occurred after initial scan, we included in the growth rate analysis only
serial aortic measurements that either preceded the dissection event or followed the dissection
event. We deliberately excluded changes in aortic size associated with the dissection event itself,
since acute dissection independently inflates aortic growth rate.
Growth rate was defined as the difference between last and first aortic diameter, divided
by the duration between tests. We calculated mean growth rate in the setting of chronic
dissection, no dissection, ascending/arch disease, and descending disease in all BA and non-BA
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patients. We also compared growth rate in type 1 versus type 2 BA, and in BA and non-BA
patients with concomitant BAV.
Bicuspid Aortic Valve
Patients in the thoracic aortic disease group were screened for presence of BAV by
reviewing operative notes and/or echocardiography reports. In patients who underwent ascending
aortic replacement, operative notes provided the most reliable source of information about aortic
valve morphology since they documented direct visual observation of the valve apparatus. For
patients who did not undergo operative intervention or in whom the nature of the aortic procedure
did not directly visualize the aortic valve, information about aortic valve morphology was
obtained from digital echocardiography reports (if performed at Yale-New Haven Hospital) or
reports on file at Yale Center for Thoracic Aortic Disease (if performed at outside institutions).
We then compared demographics, prevalence of complications, and aortic growth rate in BA and
non-BA patients with BAV.
Statistics
The two-tailed, unpaired t-test was used to evaluate the difference in aortic growth rates
and the difference in age at presentation between BA and non-BA groups and between type 1 and
type 2 BA groups. Pearson chi-square test and Fisher exact test were used to compare
proportions, including the difference in BA prevalence between aortic disease and control groups,
the difference in prevalence of ascending, arch, and descending disease in BA and non-BA
groups, and the difference in dissection rate between BA and non-BA groups and between type 1
and type 2 BA groups. Statistical significance was defined as P < 0.05.
Author Contributions
The primary author (Matthew Hornick) was involved in several aspects of this study,
including experimental design, screening for BA in scans of disease group and control group
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patients, reviewing all disease group imaging reports and chart records for radiologists’ citation of
BA, location of aortic disease, serial TAA diameter, presence of BAV, and demographic data,
and organization of results and statistical calculations. Dr. John Elefteriades conceived of this
experiment and advised the primary author (MH) during each phase. Maryann Tranquilli
provided records of consecutive aortic disease patients treated and/or seen in consultation at Yale
Center for Thoracic Aortic Disease. Dr. Remo Moomiaie was involved in study design and
assisted with screening for BA in disease group patients. Esther S. Lee generated a randomized
group of thoracic CT scans in patients without thoracic aortic disease, and assisted in screening
these control group scans for BA. Dr. Hamid Mojibian confirmed interpretations of imaging
scans (BA+/BA- and type 1/type 2) for all disease group and control group patients. Dr. John
Rizzo advised statistical methodology and confirmed all statistical calculations.

RESULTS

Table 1. Prevalence of BA in Thoracic Aortic (TA) Disease Group and Control Group
Variable
TA Disease Group Control Group P value
Total number
616
844
Total BA+ (% of total)
161 (26.1%)
138 (16.4%)
<0.001
No. male
416
396
BA+ (% of male)
109 (26.2%)
64 (16.2%)
<0.001
No. female
200
448
BA+ (% of female)
52 (26.0%)
74 (16.5%)
0.005

Prevalence of BA Variant (see Table 1)
Of 616 patients with known thoracic aortic disease, 161 patients (109 male, 52 female)
were found to have concomitant BA (26.1% prevalence). Upon reviewing all imaging reports, the
presence of BA was cited by a radiologist in only 26 (16.1%) of the 161 BA patients with aortic
disease. Of 844 control group patients without TAA or dissection, 138 patients (64 male, 74
female) were found to have BA (16.4% prevalence). BA prevalence was significantly greater in
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the thoracic aortic disease group than in the control group of patients without aortic disease
(P<0.001), and this held true for both male and female patients when considering each gender
independently (P<0.001 for males and P=0.004 for females).

Table 2. Demographics, Location, and Complications in Thoracic Aortic Disease, by BA Group
Variable
BA+
BAP value
Thoracic Aortic Disease (no.)
161
455
Sex (male)
109 (67.7%)
307 (67.5%)
1
Age at presentation (mean, yrs) 56.8
61.3
0.002
Operative repair
122 (75.8%)
339 (74.5%)
0.82
Age at repair (mean, yrs)
56.2
61.4
0.0004
Bicuspid aortic valve
43 (26.7%)
114 (25.1%)
0.68
Family history of TAA/AAA
34 (21.1%)
97 (21.3%)
1
Hypertension
101 (62.7%)
317 (69.7%)
0.11
Location of Disease
Ascending (incl. Root)
Arch
Descending

130 (80.7%)
5 (3.1%)
26 (16.2%)

369 (81.1%)
12 (2.6%)
74 (16.3%)

0.92
0.78
1

Thoracic aortic dissection
Type A
Type B
Thoracic aortic rupture

43 (26.7%)
19 (11.8%)
24 (14.9%)
5 (3.1%)

106 (23.3%)
57 (12.5%)
49 (10.8%)
11 (2.4%)

0.39
0.81
0.16
0.77

Demographics (see Table 2)
Among patients with thoracic aortic disease, patients with BA were 67.7% male and
patients without BA were 67.5% male; there was no association between BA and gender (P=1).
Relative to patients without BA, patients with BA were significantly younger at initial discovery
of thoracic aortic disease and initial operative repair. Mean age at presentation with TAA or
dissection was 56.8 years (median 58.4 years) in the BA group and 61.3 years (median 62.0
years) in the non-BA group (P=0.002). Mean age at initial operative aortic repair was 56.2 years
(median 57.8 years) in the BA group and 61.4 years (median 62.7 years) in the non-BA group
(P=0.0004). 75.8% of BA patients and 74.5% of non-BA patients underwent surgical aortic repair
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or replacement. Bicuspid aortic valve (BAV) was present in 26.7% of BA patients and 25.1% of
non-BA patients with thoracic aortic disease (P=0.68). With respect to family history, 21.1% of
BA patients and 21.3% of non-BA patients had at least one relative with thoracic or abdominal
aortic disease (P=1). Hypertension was documented in 62.7% of BA patients and 69.7% of nonBA patients, which was not a statistically significant difference (P=0.11).
Location of Disease (see Table 2)
Of the 161 thoracic aortic disease patients with BA, 130 (80.7%) had ascending disease,
26 (16.2%) had descending disease, and 5 (3.1%) had aortic arch disease. Of the 455 thoracic
aortic disease patients without BA, 369 (81.1%) had ascending disease, 74 (16.3%) had
descending disease, and 12 (2.6%) had arch disease. BA was not significantly associated with
thoracic aortic disease at any particular location (Table 2).
Prevalence of Dissection and Rupture (see Table 2)
Overall prevalence of dissection was 26.7% in BA patients (43 of 161), including 24 with
type B and 19 with type A, and 23.3% (106 of 455) in non-BA patients, including 49 with type B
and 57 with type A. There was no significant association between BA and type A (P=0.81), type
B (P=0.16), or overall dissection (P=0.39). There were 5 instances of thoracic aortic rupture in the
BA group (3.1%), and 11 instances of rupture in the non-BA group (2.4%). Difference in
prevalence of rupture between BA and non-BA groups was not statistically significant (P=0.77).
Table 3. Aortic Growth Rate (cm/yr), by BA Group (*comparison data from Coady et al. [48])
Variable
All Yale
BA- (n)
BA+ (n)
P value
patients*
(BA- vs. BA+)
All Thoracic Aortic Disease
0.10
0.09 (164)
0.29 (54)
0.003
Chronic Dissection
0.31
0.20 (33)
0.51 (13)
0.01
No Dissection
0.05
0.06 (131)
0.22 (41)
0.04
Ascending/Arch
0.09
0.06 (130)
0.12 (37)
0.44
Descending
0.12
0.20 (34)
0.66 (17)
0.001
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Figure 2. Aortic Growth Rate (cm/yr), by BA Group (―Yale‖ data from Coady et al. [48] and
Davies et al. [87])
(* denotes
statistically
significant
difference
between BA+ and
BA- groups)

*

*

*

*
*

Aortic Growth Rate (see Table 3 and Figure 2)
Follow-up ranged from 3.1 to 184.7 months. Mean aortic growth rate was 0.29 cm/year in
all BA patients (mean follow-up 32.8 months), compared to 0.09 cm/year in all non-BA patients
(mean follow-up 31.7 months). This difference in overall growth rate between BA and non-BA
patients was statistically significant (P=0.003). Furthermore, subgroup analysis revealed a
significant association between BA and elevated aortic growth rate in patients with descending
aortic disease, as well as in patients both with and without chronic dissection (P=0.01 and P=0.04,
respectively). In ascending aortic disease, BA patients also demonstrated a faster rate of aortic
growth, but this association between BA and ascending aortic expansion was not statistically
significant.

29

Table 4. Demographics, Location, Dissection, and Rupture in BA Patients, by BA Type
Variable
Type 1 BA
Type 2 BA
P value
No.
108
53
No male (%)
76 (70.4%)
33 (62.3%)
0.30
Age at presentation (mean,
55.7
58.9
0.17
yrs)
Operative repair
83 (76.9%)
39 (73.6%)
0.65
Age at repair (mean, yrs)
55.7
57.4
0.55
Bicuspid aortic valve
29 (26.8%)
14 (26.4%)
1
Family history of TAA/AAA 23 (21.3%)
11 (20.8%)
0.92
Hypertension
68 (63.0%)
33 (62.3%)
0.92
Location of Disease
Ascending (incl. Root)
Arch
Descending

87 (80.6%)
3 (2.8%)
18 (16.7%)

43 (81.1%)
2 (3.8%)
8 (15.1%)

0.92
1
1

Thoracic aortic dissection
Type A
Type B
Thoracic aortic rupture

26 (24.1%)
10 (9.3%)
16 (14.8%)
2 (1.9%)

17 (32.1%)
9 (17.0%)
8 (15.1%)
3 (5.7%)

0.28
0.15
1
0.33

Growth rate (cm/yr)

0.31 (n=37)

0.25 (n=17)

0.61

BA Type (see Table 4)
Of 161 BA patients, there were 108 patients with type 1 BA and 53 patients with type 2
BA. Patients with type 1 BA presented 3.2 years earlier and demonstrated a slightly higher mean
growth rate than patients with type 2 BA, but these differences were not statistically significant
(P=0.17 and P=0.61, respectively). Furthermore, there were no significant differences in
operative aortic repair, age at operation, prevalence of bicuspid aortic valve, family history of
aortic disease, or presence of hypertension between type 1 and type 2 BA groups. There were also
no significant differences in prevalence of dissection or rupture between groups (Table 4).
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Table 5. Bicuspid Aortic Valve (BAV) Patients, by BA group
Variable
BA+
BANo. BAV
43
114
Hypertension
19 (44.2%)
68 (59.6%)
Age at presentation (mean, yrs) 48.3
53.8
Operative repair
39 (90.7%)
102 (89.5%)
Age at repair (mean, yrs)
49.2
57.0
Growth rate (cm/yr)
0.26 (n=14)
0.06 (n=31)

P value
0.08
0.040
1
0.002
0.018

BA in Patients with BAV (see Table 5)
Among patients with BAV and thoracic aortic disease, hypertension was present in 44%
of BA patients and 59.6% of non-BA patients, which was not a statistically significant difference
(P=0.08). Mean age at presentation with aortic disease was 48.3 years in BA patients with BAV
and 53.8 years in non-BA patients with BAV, which was a significant difference (P=0.040).
Mean age at operative repair was 49.2 years in the BA group and 57.0 years in the non-BA group,
which was also a significant difference (P=0.002). BA patients with BAV demonstrated higher
mean aortic growth rate than non-BA patients with BAV (P=0.018). There was no association
between BA and prevalence of operative repair in BAV patients.

Table 6. Ascending Aortic Disease, by BA group
Variable
BA+
No. with ascending disease
130
Age at presentation (mean,
55.4
yrs)
Operative repair
105 (80.8%)
Age at repair (mean, yrs)
55.9
No. BAV (%)
42 (32.3%)

BA369
59.8
287 (77.8%)
60.7
112 (30.4%)

P value
0.002
0.48
0.002
0.68

BA in Ascending Aortic Disease (see Table 6)
BA patients with ascending aortic disease presented at a significantly younger age than
non-BA patients with ascending disease (P=0.002). BA patients also underwent ascending aortic
operation at a significantly younger age than non-BA patients with ascending disease (P=0.002).
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There was no significant difference in prevalence of operative repair between BA and non-BA
patients with ascending disease. 32.3% of BA patients with ascending disease and 30.5% of nonBA patients with ascending disease had concomitant BAV (P=0.68)

Table 7. Descending Aortic Disease, by BA group
Variable
BA+
BANo. with descending disease
26
74
Age at presentation (mean,
63.5
67.3
yrs)
Operative repair
14 (53.8%)
44 (59.5%)
Age at repair (mean, yrs)
59.5
64.4
No. BAV (%)
1 (3.8%)
2 (2.7%)

P value
0.25
0.62
0.26
1

BA in Descending Aortic Disease (see Table 7)
BA patients with descending aortic disease presented at a younger age than non-BA
patients with descending disease (63.5 years versus 67.3 years), but this difference was not
statistically significant (P=0.25). Mean age at initial aortic operation was lower in the BA group
as well, but this trend did not reach statistical significance (P=0.26). There was no association
between BA and prevalence of operative repair in patients with descending aortic disease.

DISCUSSION

Historically, BA has been considered a clinically insignificant variant of aortic arch
anatomy. Isolated reports of complex aortic arch operations and a few studies of aortic anatomy
in women with Turner’s syndrome have hinted at a potential association between BA, BAV, and
thoracic aortic disease, but with very little substantial evidence [25-37]. To our knowledge, this
study is the first to document a statistically significant association between congenital BA variant
and thoracic aortic disease.
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We found that BA was significantly more common in patients with thoracic aortic
disease (26.1% prevalence in patients with TAA, thoracic aortic dissection, or rupture) than in the
general population of patients without thoracic aortic disease (16.4% prevalence in control group
patients without TAA, dissection, or rupture). The presence of BA was cited by radiologists in
only 26 (16.1%) of the 161 BA patients in the thoracic aortic disease group, suggesting that
radiologists overlook or underreport this anatomic variant, even when specifically monitoring the
aorta. This trend likely reflects the popular sentiment that BA is a ―normal‖ variant that does not
warrant reporting.
In our series, BA was not significantly associated with location of thoracic aortic disease,
with prevalence of aortic disease at any given location virtually equivalent across BA and nonBA groups. Thoracic aortic dissection was slightly more prevalent in patients with BA (26.7%)
than in patients without BA (23.3%), but this difference was not statistically significant. Since the
vast majority of dissections occurred prior to the initial scan, we were unable to determine the
mean aortic diameter at which BA patients initially dissected. Further investigation will be
required to establish whether the presence of BA should impact surgical intervention criteria for
TAA.
With respect to growth rate, our results indicate that BA is associated with a significantly
higher rate of aortic expansion – 0.29 cm/year in the BA group, compared to 0.09 cm/year in the
non-BA group. This association between BA and growth rate was particularly pronounced in
descending aortic disease and in the setting of chronic dissection, with mean growth rate 0.66
cm/year and 0.51 cm/year, respectively, in these two subgroups of BA patients. Thus, although
BA does not appear to be associated with location of disease, the variant may differentially
influence growth rate in different regions of the aorta. Similarly, while BA may not be directly
associated with a higher prevalence of dissection, it may very well contribute to the progression
of aortic dilatation once dissection occurs. Among patients with ascending aortic disease, BA
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patients trended towards a higher growth rate as well (0.12 cm/year, compared to 0.06 cm/year in
non-BA patients), but this difference was not statistically significant.
BA patients also presented with aortic disease approximately 4.5 years earlier than nonBA patients, and underwent initial aortic operation over 5 years earlier, on average. The younger
presentation and repair observed in BA patients dovetails to our findings with respect to
accelerated aortic growth in this group. Interestingly, despite a statistically insignificant
relationship with growth rate in ascending aortic disease, BA was nonetheless associated with
significantly earlier presentation and repair in patients with ascending aortic disease. By the same
token, despite a statistically significant association with growth rate in descending aortic disease,
BA was not significantly associated with earlier presentation and repair in patients with
descending aortic disease. That being said, results trend toward accelerated growth rate, earlier
presentation, and earlier repair in both ascending and descending aortic disease patients with BA,
and greater statistical power would likely resolve these inconsistencies.
We used an arithmetic method to calculate mean growth rate (defined as last diameter
minus first diameter, divided by duration between measurements), which has been criticized in
the past for inflating growth rate estimates [57,60]. In prior studies, however, much of the error
attributed to this technique has been related to the deliberate truncation of negative and null
growth rates; to minimize this source of growth rate inflation, negative and null growth rates were
included in this analysis. It is worth noting that the mean arithmetic growth rate that we observed
in non-BA patients (0.09 cm/year) nearly matched the mean growth rate calculated via regression
analysis (0.10 cm/year) in a previous study of Yale Center for Thoracic Aortic Disease patients
[48]. Therefore, despite the host of inconsistencies and technical challenges inherent to serial
aortic size measurements and growth rate calculations [56], there does appear to be some
consistency between studies and between methods of calculation. Moreover, any effects related to
methodology would be expected to distribute evenly across BA and non-BA groups, which lends
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further credence to the relatively higher growth rate observed in the BA group. Our findings
demonstrate that while aortic disease in non-BA patients is indeed an indolent process, BA seems
to be associated with a markedly elevated and far less indolent rate of aortic expansion.
There was no significant association between BA and BAV in this study, which
challenges vague suggestions in the literature as to a possible relationship between these two
congenital anatomic variants [34-37]. This is a relevant finding because it indicates that BAV is
not a confounding variable in the observed association between BA and thoracic aortic disease,
despite the already well-established association between BAV and ascending aortopathy.
However, our results do suggest that in patients with BAV, the concomitant presence of BA is
associated with even earlier presentation and operative repair, and more rapid aortic growth rate.
These results imply that the presence of BA (or some unidentified associated factor) may
essentially exacerbate an already accelerated aortopathy in BAV patients.
There were few clinical differences observed between patients with type 1 and type 2
BA. Patients with type 1 BA presented with aortic disease 3.2 years earlier than patients with type
2 BA and demonstrated a slightly higher overall growth rate (0.31 cm/year, compared to 0.25
cm/year in type 2 BA). Given the relatively low number of patients in each group, however, none
of these differences reached statistical significance. Both variants represent a fairly radical
departure from typical aortic arch anatomy, and it is difficult to intuit which variant is
intrinsically more ―abnormal‖ – in type 1 BA, there is a large common trunk branching from the
proximal arch, and in type 2 BA, the takeoff of the L common carotid is displaced far from its
typical origin. Further studies with larger patient populations will be required to better distinguish
between the clinical significance of these two BA configurations.
One important limitation of this study was our failure to address the specific
pathophysiologic mechanisms by which a congenital BA contributes or relates to the later
development of thoracic aortic disease. We have identified an association, but we have no
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definitive explanation as to why this association exists. Clinical aortopathy is an extremely
complex process, and it seems likely that several variables contribute to aortic disease in BA
patients.
On the one hand, BA may predispose to aortic dilatation through altered flow dynamics
within the walled area of the variant. As already mentioned, BA represents a fairly striking
deviation from normal aortic arch anatomy, and a mechanical explanation for this association
seems entirely plausible. One thought is that the common trunk in type 1 BA creates, at its origin,
a point of functionally increased aortic diameter, thereby increasing circumferential wall tension
in this region by extension of Laplace’s law [40]. If this were indeed the case, however, we would
expect a disproportionately high number of arch and proximal descending aortic disease in BA,
which is not what we observed in this study. Another possibility is that the altered branching
pattern in BA predisposes to abnormal flow patterns in the aorta, which exert increased stress on
particular regions of the aortic wall and ultimately accelerate dilatation. Magnetic resonance
velocity mapping studies have demonstrated that both the caliber of the aorta and the
configuration of the arch vessels impact aortic flow dynamics [101,102], so it seems likely that
BA may exert at least some influence in this regard. We suspect that aortic modeling, dynamic
flow studies, and a better understanding of the hemodynamics of type 1 and type 2 BA will shed
light on the mechanical consequences of BA.
Alternatively, BA may be associated with TAA due to concomitant congenital
abnormalities in the structure of the aortic wall, as is well-established in patients with BAV [7084]. We demonstrated in this study that the presence of BA seems to further exacerbate the
clinical picture characteristic of BAV, but it is unclear if BA represents an exaggeration of BAVassociated pathology or a distinct pathologic process altogether. Since BA, like BAV, is a
congenital variant of outflow tract anatomy, the notion of an associated predisposition to
pathologic aortic tissue remodeling is certainly compelling. Further study, presumably
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investigating the molecular properties of aortic tissue in the setting of BA (with and without
BAV) is necessary to investigate this possibility. Given the particularly strong association
between BA and growth rate in descending thoracic aortic disease, it will be equally as important
to study characteristics of descending aortic tissue in patients with BA. And lastly, despite the
observed non-association between BA and family history of aortic disease in this study, the
potential heritability of BA and its role in the later development of aortic disease cannot be ruled
out and certainly deserves future consideration.
A second limitation of this study was our strategy for classifying disease location, which
confined patients to one specific group rather than accounting for dilatation in multiple regions of
the aorta. Many patients ultimately developed TAAs in a second or even a third location, but only
the initial region of maximal dilatation factored into our classification scheme.
A third limitation was our failure to age-match the control group to the thoracic aortic
disease group. Mean age of patients in the control group (55.7 years) was younger than the mean
age at which patients in the disease group presented with TAA or dissection (56.8 years in
patients with BA and 61.3 years in patients without BA). This discrepancy is relevant because
certain patients in the control group may develop TAA or dissection as they approach the age at
which aortic disease is typically detected, which would exclude these patients from the control
group altogether. However, since thoracic aortic disease is relatively rare in the general
population [43], we would expect this age-related cross-over number to be vanishingly small.
Moreover, age has no bearing on the absolute number of patients with BA, since BA is a
congenital variant that is present, and apparent, from birth.
A fourth limitation pertains to the selection bias inherent to this study’s retrospective
case-control design. We have determined prevalence of BA in (1) a population of patients
referred to the Yale Center for Thoracic Aortic Disease and (2) a population of patients without
thoracic aortic disease who underwent thoracic imaging at Yale-New Haven Hospital for various
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reasons, including lung cancer, breast cancer, lymphoma, chest pain, and other indications.
Although the Yale Center for Thoracic Aortic Disease provides both medical and surgical care to
a broad catchment area, the group of patients referred to Yale may be biased toward relatively
complex cases; therefore, we acknowledge that all findings pertaining to the prevalence of
aneurysm, dissection, and rupture do not necessarily reflect the general population of patients
with thoracic aortic disease. Similarly, the control group of patients is not truly representative of
the general population of patients without aortic disease, since these control patients were referred
for thoracic imaging, which is certainly not a common or ―general‖ occurrence. It is possible,
though presumably unlikely, that certain pathologies for which control group patients were
referred are positively or negatively associated with BA, and thus confounded our results. What
we can say for certain is that none of the patients in the control group, at time of thoracic imaging
or subsequently, have developed thoracic aortic disease by our definitions.
We are unable to address true incidence of aortic disease in patients with congenital BA
variant, because this would require decades of prospective monitoring for the development and
progression of dilatation in BA and control groups. We did follow aortic size longitudinally, but
the retrospective nature of this study biases these findings because certain patients were
monitored at more regular intervals and/or for longer periods of time. Most patients referred to
Yale Center for Thoracic Aortic Disease undergo periodic imaging to monitor aortic size at least
once every two years until operation; however, because aortic disease is often detected late in its
course, many patients in this study had only a brief interval of serial follow-up prior to repair. Our
growth rate data thus represent a fairly limited snapshot of what is in truth an extremely dynamic
disease process.
Our rigid definition of thoracic aortic aneurysm fails to account for the aorta’s inherent
gradual dilatation over the course of the lifetime. The aorta naturally expands due to loss of vessel
elasticity with aging [65,66], and yet we labeled any thoracic aorta with diameter greater than 4.0
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cm as aneurysmal, regardless of patient age. How to precisely distinguish a patient with clinically
relevant ―aortic disease‖ remains a point of contention, since the boundaries are somewhat blurry.
A 3.7 cm ascending aorta in a 25-year old patient, although not ―aneurysmal‖ by our strict size
criterion, certainly seems far more predisposed to dissection or rupture than an ―aneurysmal‖ 4.1
cm ascending aorta in an 80 year-old patient. This quandary, once again, underscores the need for
prospective longitudinal studies that will facilitate our understanding of the heterogeneous natural
history of aortic dilatation.
As previously discussed, several autopsy studies and imaging reviews have measured
prevalence of BA in the general population, with great variability in results. Much of this
variability may be attributed to the somewhat ambiguous definition of BA, technical limitations
in imaging the takeoff points of the great vessels, inconsistent interpretations of arch anatomy by
radiologists, and differences in study populations [1,56]. We defined BA as ―a point of separation
of the innominate and left common carotid arteries cephalad to the plane of greater curvature of
the arch.‖ Unfortunately, as implied by this definition, identification of BA requires a partially
subjective assumption about where the plane of greater aortic curvature would be if not for the
takeoff of the innominate artery, which in itself explains a great deal of inter-observer variation.
Berko et al. recently reported a 27.4% BA prevalence in a large review of consecutive CTA scans
[17], which is the highest estimate (in non-syndromic patients) in the literature. Many of these
CTA scans were performed in patients with suspected aortic dissection [17], which may have
skewed the observed BA frequency in light of the potential relationship between BA and aortic
disease. Here we report a relatively lower prevalence of BA – 26.1% in the thoracic aortic disease
group and 16.4% in the control group. For purposes of this study, which seeks to define the
clinical associations of BA, the differences observed between the aortic disease group and control
group are more relevant than the precise prevalence of BA per se. In our series, the same
radiologist, using consistent criteria for identifying BA in both groups and sophisticated imaging
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at an Aortic Center, found a significant difference in BA prevalence between patients with and
without thoracic aortic disease.
To this point, BA has been regarded as a relatively insignificant variant of aortic arch
anatomy. General apathy towards BA is manifest in its frequent omission from imaging reports,
with only 16.1% of radiologists citing BA in scans specifically monitoring patients with aortic
disease. This study demonstrates a strong association between BA and the presence and natural
history of thoracic aortic disease, which we hope will encourage radiologists to consistently
report BA anatomy. Moreover, BA is present in approximately one-quarter of all patients with
thoracic aortic disease, rendering its detection all the more important. We recognize that a
substantial number of patients with congenital BA may never go on to develop aortic disease, and
for this reason we do not advise serial aortic screening in every person with BA. However, aortic
disease patients with concomitant BA demonstrate a substantially elevated aortic growth rate and
an earlier age at repair, which seems to warrant more careful follow-up in this particular
population. In patients with thoracic aortic disease and BA, therefore, we suggest serial imaging
at more frequent intervals to monitor for changes in aortic caliber. Aortic disease patients with
BA and BAV appear to be at particular risk for an accelerated disease course, and deserve
especially meticulous attention. As mentioned, further study is necessary to determine if the
presence of BA should impact criteria for surgical intervention.
Parenthetically, as we have mentioned and Griepp has pointed out (personal
communication), the name ―bovine aortic arch‖ is not anatomically correct. The cow's aorta does
not have either of the configurations typically subsumed under the heading ―bovine arch,‖ namely
a common origin of the innominate and left common carotid arteries or a left common carotid
artery originating directly from the innominate artery [1]. We suggest the new name ―common
origin aortic arch‖ for the anatomic patterns classically described as ―bovine aortic arch‖; this
alternate designation is succinct and accurately descriptive.
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CONCLUSIONS
(1) There has been a paucity of literature addressing the clinical significance of BA, and
consequently BA has been considered a ―normal‖ variant of aortic arch anatomy that is typically
not cited in radiology reports. (2) Our data demonstrate a significant association between the
presence of congenital BA variant and the development of thoracic aortic disease. The
mechanism underlying this association is unknown. (3) We found a significant association
between presence of BA and increased rate of aortic expansion, particularly in descending aortic
disease and in chronic dissection. BA was also associated with earlier age at presentation and
initial operative repair. (4) There was no association between BA and bicuspid aortic valve
(BAV). In patients with BAV and thoracic aortic disease, concomitant BA was associated with
more rapid growth rates, earlier presentation, and earlier repair. (5) In light of these findings, BA
should not be considered a clinically insignificant anatomic variant. BA is a marker for potential
development and progression of thoracic aortic disease, and warrants more frequent serial
imaging follow-up if present in patients with thoracic aortic disease. We encourage radiologists to
take note of aortic arch anatomy on any thoracic scan in any age group (even those obtained for
non-cardiac purposes), and consistently report BA if incidentally discovered. (6) Since ―bovine
aortic arch‖ is a misnomer, we propose the name ―common origin aortic arch‖ to describe this
group of variant configurations.
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